The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting-Reference-Cited by-同舟云学术

The Cerebrospinal Fluid Aβ1–42/Aβ1–40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting

Published:2017-09-18 Issue:2 Volume:60 Page:561-576
ISSN:1387-2877
Container-title:Journal of Alzheimer's Disease
language:
Short-container-title:JAD

Author:

Niemantsverdriet Ellis¹,Ottoy Julie²,Somers Charisse¹,De Roeck Ellen¹³,Struyfs Hanne¹,Soetewey Femke¹,Verhaeghe Jeroen²,Van den Bossche Tobi⁴⁵⁶,Van Mossevelde Sara⁴⁵⁶,Goeman Johan⁶,De Deyn Peter Paul¹⁶,Mariën Peter⁶⁷,Versijpt Jan⁸,Sleegers Kristel⁴⁵,Van Broeckhoven Christine⁴⁵,Wyffels Leonie²⁹,Albert Adrien⁹,Ceyssens Sarah⁹,Stroobants Sigrid²⁹,Staelens Steven²,Bjerke Maria¹,Engelborghs Sebastiaan¹⁶

Affiliation:

1. Reference Center for Biological Markers of Dementia (BIODEM), Laboratory of Neurochemistry and Behavior, Institute Born-Bunge, UAntwerp, Antwerp, Belgium

2. Molecular Imaging Center Antwerp (MICA), UAntwerp, Antwerp, Belgium

3. Faculty of Psychology and Educational Sciences, Vrije Universiteit Brussels, Brussels, Belgium

4. VIB-UAntwerp Center for Molecular Neurology, Antwerp, Belgium

5. Laboratory of Neurogenetics, Institute Born-Bunge, UAntwerp, Antwerp, Belgium

6. Department of Neurology and Memory Clinic, Hospital Network Antwerp (ZNA) Middelheim and Hoge Beuken, Antwerp, Belgium

7. Clinical and Experimental Neurolinguistics, CLIN, Vrije Universiteit Brussel (VUB), Brussels, Belgium

8. Vrije Universiteit Brussel(VUB), University Hospital Brussels (UZ Brussel), Department of Neurology, Brussels, Belgium

9. Departmentof Nuclear Medicine, Antwerp University Hospital, Antwerp, Belgium

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference63 articles.

1. Cellular processing of beta-amyloid precursor protein and the genesis of amyloid beta-peptide.;Haass;Cell,1993

2. A novel pathway for amyloid precursor protein processing;Portelius;Neurobiol Aging,2011

3. Tracking pathophysiological processes in Alzheimer’s disease: An updated hypothetical model of dynamic biomarkers;Jack;Lancet Neurol,2013

4. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: A prospective cohort study;Villemagne;Lancet Neurol,2013

5. Abeta40 and Abeta42 amyloid fibrils exhibit distinct molecular recycling properties;Sanchez;J Am Chem Soc,2011

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer’s disease: a review on the current trends of the effective diagnosis and therapeutics;Frontiers in Aging Neuroscience;2024-08-09

2. Biomarker-Based Precision Therapy for Alzheimer’s Disease: Multidimensional Evidence Leading a New Breakthrough in Personalized Medicine;Journal of Clinical Medicine;2024-08-08

3. Advances in Blood Biomarkers for Alzheimer’s Disease: Ultra-Sensitive Detection Technologies and Impact on Clinical Diagnosis;Degenerative Neurological and Neuromuscular Disease;2024-07

4. ArcheD, a residual neural network for prediction of cerebrospinal fluid amyloid‐beta from amyloid PET images;European Journal of Neuroscience;2024-04-04

5. Sensitive detection of multiple blood biomarkers via immunomagnetic exosomal PCR for the diagnosis of Alzheimer’s disease;Science Advances;2024-03-29